MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia

Experimental Hematology

Volumn 43, Issue 10, 2015, Pages 858-868.e7

  Gentner, Bernhard ^a   Pochert, Nicole ^b   Rouhi, Arefeh ^b   Boccalatte, Francesco ^a   Plati, Tiziana ^a   Berg, Tobias ^c   Sun, Su Ming ^d   Mah, Sarah M ^e   Mirkovic Hösle, Milijana ^f   Ruschmann, Jens ^e   Muranyi, Andrew ^b   Leierseder, Simon ^g   Argiropoulos, Bob ^h   Starczynowski, Daniel T ⁱ   Karsan, Aly ^j   Heuser, Michael ^k   Hogge, Donna ^c   Camargo, Fernando D ^l   Engelhardt, Stefan ^g   Döhner, Hartmut ^b   Buske, Christian ^b   Jongen Lavrencic, Mojca ^d   Naldini, Luigi ^a   Humphries, R Keith ^e   Kuchenbauer, Florian ^b   more..

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

^f UNIVERSITY OF MUNICH   (Germany)

^g Technical University   (Germany)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^j BRITISH COLUMBIA CANCER AGENCY   (Canada)

^k HANNOVER MEDICAL SCHOOL   (Germany)

^l BOSTON CHILDREN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; MICRORNA 223; VIRUS VECTOR; MICRORNA; MIRN223 MICRORNA, HUMAN; MIRN223 MICRORNA, MOUSE; RNA;

ACUTE MYELOBLASTIC LEUKEMIA; ACUTE MYELOMONOCYTIC LEUKEMIA; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ERYTHROPOIESIS; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; LYMPHOPOIESIS; MALE; MOUSE; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN DEPLETION; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; CANCER STEM CELL; EXPERIMENTAL NEOPLASM; FETUS BLOOD; GENETICS; HEMATOPOIETIC STEM CELL; KNOCKOUT MOUSE; METABOLISM; MIDDLE AGED; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE;

ADULT; ANIMALS; CELL PROLIFERATION; ERYTHROPOIESIS; FEMALE; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; LYMPHOPOIESIS; MALE; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; MICRORNAS; MIDDLE AGED; NEOPLASMS, EXPERIMENTAL; NEOPLASTIC STEM CELLS; RNA, NEOPLASM;

EID: 84942512732     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2015.05.018     Document Type: Article

References (44)

1. Grasedieck S., Sorrentino A., Langer C., et al. Circulating microRNAs in hematological diseases: principles, challenges, and perspectives. Blood 2013, 121:4977-4984.
2. Petriv O.I., Hansen C.L., Humphries R.K., Kuchenbauer F. Probing the complexity of miRNA expression across hematopoiesis. Cell Cycle 2011, 10:2-3.
3. Starczynowski D.T., Kuchenbauer F., Wegrzyn J., et al. MicroRNA-146a disrupts hematopoietic differentiation and survival. Exp Hematol 2011, 39:167-178.e164.
4. Petriv O.I., Kuchenbauer F., Delaney A.D., et al. Comprehensive microRNA expression profiling of the hematopoietic hierarchy. Proc Natl Acad Sci U S A 2010, 107:15443-15448.
5. Kuchenbauer F., Morin R.D., Argiropoulos B., et al. In-depth characterization of the microRNA transcriptome in a leukemia progression model. Genome Res 2008, 18:1787-1797.
6. Lechman E.R., Gentner B., van Galen P., et al. Attenuation of miR-126 activity expands HSC in vivo without exhaustion. Cell Stem Cell 2012, 11:799-811.
7. Babar I.A., Cheng C.J., Booth C.J., et al. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci U S A 2012, 109:E1695-1704.
8. Copley M.R., Babovic S., Benz C., et al. The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells. Nat Cell Biol 2013, 15:916-925.
9. Liu Q., Zhang M., Jiang X., et al. miR-223 suppresses differentiation of tumor-induced CD11b(+) Gr1(+) myeloid-derived suppressor cells from bone marrow cells. Int J Cancer 2011, 129:2662-2673.
10. Morin R.D., O'Connor M.D., Griffith M., et al. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res 2008, 18:610-621.
11. Thai T.H., Calado D.P., Casola S., et al. Regulation of the germinal center response by microRNA-155. Science 2007, 316:604-608.
12. Zonari E., Pucci F., Saini M., et al. A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice. Blood 2013, 122:243-252.
13. Kuchenbauer F., Mah S.M., Heuser M., et al. Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells. Blood 2011, 118:3350-3358.
14. Fazi F., Rosa A., Fatica A., et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005, 123:819-831.
15. Leierseder S., Petzold T., Zhang L., Loyer X., Massberg S., Engelhardt S. MiR-223 is dispensable for platelet production and function in mice. Thromb Haemost 2013, 110:1207-1214.
16. Chen C.Z., Li L., Lodish H.F., Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86.
17. Johnnidis J.B., Harris M.H., Wheeler R.T., et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008, 451:1125-1129.
18. Fazi F., Racanicchi S., Zardo G., et al. Epigenetic Silencing of the Myelopoiesis Regulator microRNA-223 by the AML1/ETO Oncoprotein. Cancer Cell 2007, 12:457-466.
19. Pulikkan J.A., Dengler V., Peramangalam P.S., et al. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010, 115:1768-1778.
20. Fukao T., Fukuda Y., Kiga K., et al. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 2007, 129:617-631.
21. Gentner B., Visigalli I., Hiramatsu H., et al. Identification of hematopoietic stem cell-specific miRNAs enables gene therapy of globoid cell leukodystrophy. Sci Transl Med 2010, 2:58ra84.
22. Brown B.D., Gentner B., Cantore A., et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 2007, 25:1457-1467.
23. Gentner B., Schira G., Giustacchini A., et al. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 2009, 6:63-66.
24. Zhuang G., Meng C., Guo X., et al. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 2012, 125:2892-2903.
25. Zardo G., Ciolfi A., Vian L., et al. Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. Blood 2012, 119:4034-4046.
26. Felli N., Pedini F., Romania P., et al. MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica 2009, 94:479-486.
27. Vian L., Di Carlo M., Pelosi E., et al. Transcriptional fine-tuning of microRNA-223 levels directs lineage choice of human hematopoietic progenitors. Cell Death Differ 2014, 21:290-301.
28. Heuser M., Argiropoulos B., Kuchenbauer F., et al. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in AML patients. Blood 2007, 110:1639-1647.
29. Argiropoulos B., Palmqvist L., Yung E., et al. Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3. Exp Hematol 2008, 36:845-859.
30. Sun S.M., Rockova V., Bullinger L., et al. The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML. Leukemia 2013, 27:100-106.
31. Dohner H., Estey E.H., Amadori S., et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010, 115:453-474.
32. Kuchenbauer F., Feuring-Buske M., Buske C. AML1-ETO needs a partner: new insights into the pathogenesis of t(8;21) leukemia. Cell Cycle 2005, 4:1716-1718.
33. Schessl C., Rawat V.P., Cusan M., et al. The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice. J Clin Invest 2005, 115:2159-2168.
34. Thorsteinsdottir U., Kroon E., Jerome L., Blasi F., Sauvageau G. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia. Mol Cell Biol 2001, 21:224-234.
35. Somervaille T.C., Cleary M.L. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 2006, 10:257-268.
36. Wilhelm B.T., Briau M., Austin P., et al. RNA-seq analysis of 2 closely related leukemia clones that differ in their self-renewal capacity. Blood 2011, 117:e27-38.
37. Daschkey S., Rottgers S., Giri A., et al. MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways. PLoS One 2013, 8:e56334.
38. Miller P.H., Cheung A.M., Beer P.A., et al. Enhanced normal short-term human myelopoiesis in mice engineered to express human-specific myeloid growth factors. Blood 2013, 121:e1-e4.
39. Debernardi S., Skoulakis S., Molloy G., Chaplin T., Dixon-McIver A., Young B.D. MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 2007, 21:912-916.
40. Eyholzer M., Schmid S., Schardt J.A., Haefliger S., Mueller B.U., Pabst T. Complexity of miR-223 regulation by CEBPA in human AML. Leuk Res 2010, 34:672-676.
41. Eppert K., Takenaka K., Lechman E.R., et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 2011, 17:1086-1093.
42. Metzeler K.H., Maharry K., Kohlschmidt J., et al. A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia. Leukemia 2013, 27:2023-2031.
43. Heuser M., Yun H., Berg T., et al. Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complex. Cancer Cell 2011, 20:39-52.
44. Ramsingh G., Jacoby M.A., Shao J., et al. Acquired copy number alterations of miRNA genes in acute myeloid leukemia are uncommon. Blood 2013, 122:e44-e51.